Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 11 studies | 33% ± 15% | |
| endothelial cell of artery | 7 studies | 62% ± 21% | |
| capillary endothelial cell | 6 studies | 47% ± 24% | |
| vein endothelial cell | 6 studies | 50% ± 29% | |
| fibroblast | 4 studies | 20% ± 5% | |
| glomerular endothelial cell | 3 studies | 22% ± 3% |
Insufficient scRNA-seq data for expression of CLEC3B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 94% | 1185.85 | 611 / 653 | 98% | 38.35 | 593 / 605 |
| kidney | 98% | 1353.79 | 87 / 89 | 80% | 36.60 | 724 / 901 |
| breast | 97% | 2783.22 | 443 / 459 | 79% | 11.00 | 880 / 1118 |
| adrenal gland | 82% | 591.81 | 212 / 258 | 81% | 28.21 | 186 / 230 |
| lung | 98% | 2575.72 | 566 / 578 | 59% | 8.58 | 683 / 1155 |
| brain | 45% | 264.90 | 1188 / 2642 | 86% | 14.90 | 608 / 705 |
| bladder | 90% | 1239.62 | 19 / 21 | 36% | 4.77 | 179 / 504 |
| prostate | 43% | 287.54 | 105 / 245 | 79% | 9.62 | 395 / 502 |
| skin | 87% | 1592.58 | 1570 / 1809 | 35% | 4.24 | 164 / 472 |
| intestine | 81% | 952.87 | 778 / 966 | 41% | 4.89 | 214 / 527 |
| uterus | 88% | 795.65 | 149 / 170 | 21% | 2.07 | 98 / 459 |
| adipose | 99% | 4061.90 | 1193 / 1204 | 0% | 0 | 0 / 0 |
| heart | 98% | 1840.44 | 843 / 861 | 0% | 0 | 0 / 0 |
| spleen | 97% | 2827.99 | 234 / 241 | 0% | 0 | 0 / 0 |
| esophagus | 71% | 1019.10 | 1021 / 1445 | 22% | 2.00 | 40 / 183 |
| blood vessel | 91% | 1195.87 | 1219 / 1335 | 0% | 0 | 0 / 0 |
| liver | 17% | 75.74 | 38 / 226 | 74% | 10.09 | 299 / 406 |
| stomach | 46% | 333.19 | 164 / 359 | 41% | 3.62 | 118 / 286 |
| pancreas | 0% | 1.34 | 1 / 328 | 75% | 10.29 | 133 / 178 |
| eye | 0% | 0 | 0 / 0 | 64% | 5.18 | 51 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 5.82 | 17 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 38% | 2.30 | 17 / 45 |
| ovary | 31% | 232.38 | 55 / 180 | 5% | 0.87 | 22 / 430 |
| muscle | 31% | 183.15 | 250 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.72 | 3 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001503 | Biological process | ossification |
| GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
| GO_0010756 | Biological process | positive regulation of plasminogen activation |
| GO_0030282 | Biological process | bone mineralization |
| GO_0005615 | Cellular component | extracellular space |
| GO_0001652 | Cellular component | granular component |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0031089 | Cellular component | platelet dense granule lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0036143 | Molecular function | kringle domain binding |
| GO_0008201 | Molecular function | heparin binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0030246 | Molecular function | carbohydrate binding |
| Gene name | CLEC3B |
| Protein name | C-type lectin domain family 3 member B Tetranectin (TN) (C-type lectin domain family 3 member B) (Plasminogen kringle 4-binding protein) |
| Synonyms | TNA |
| Description | FUNCTION: Tetranectin binds to plasminogen and to isolated kringle 4. May be involved in the packaging of molecules destined for exocytosis. Plays a role in retinal function . . |
| Accessions | P05452 E9PHK0 ENST00000428034.1 ENST00000296130.5 |
